Firefly Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 26-12-2024
- Paid Up Capital ₹ 0.50 M
as on 26-12-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 4.92%
(FY 2022)
- Profit -212.25%
(FY 2022)
- Ebitda 34.38%
(FY 2022)
- Net Worth -22.61%
(FY 2022)
- Total Assets 28.40%
(FY 2022)
About Firefly Life Sciences
The Corporate was formerly known as Firefly Industrial Designing Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Shiva Subramanian, Nandita Abreo, and Priyadarshini Mahalingashetty serve as directors at the Company.
- CIN/LLPIN
U74900KA2012PTC062429
- Company No.
062429
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Feb 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- LocationBangalore, Karnataka
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Firefly Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shiva Subramanian  | Director | 06-Feb-2012 | Current |
| Nandita Abreo | Director | 06-Feb-2012 | Current |
| Priyadarshini Mahalingashetty | Director | 23-Nov-2019 | Current |
Financial Performance of Firefly Life Sciences.
Firefly Life Sciences Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.92% increase. The company also saw a substantial fall in profitability, with a 212.25% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Firefly Life Sciences?
Unlock access to Firefly Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Potential Health Development Private LimitedActive 10 years 5 monthsShiva Subramanian and Nandita Abreo are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Firefly Life Sciences?
Unlock and access historical data on people associated with Firefly Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Firefly Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Firefly Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
